Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | 225Ac-FPI-2059 |
Trade Name | |
Synonyms | [225-Ac]-FPI-2059|Actinium Ac 225 FPI-2059 |
Drug Descriptions |
225Ac-FPI-2059 is a radiotherapy comprising the alpha radiation-emitting radionuclide actinium-225 linked to a molecule that targets NTSR1, which delivers radiation to NSTR1-expressing tumor cells, potentially leading to inhibition of tumor growth (Cancer Res (2023) 83 (7_Supplement): 5045). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C198218 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
225Ac-FPI-2059 | 225Ac-FPI-2059 | 0 | 1 |